HOME >> BIOLOGY >> NEWS
Two cholesterol-lowering statin drugs reduce another marker of coronary-artery disease

DALLAS Two out of three statins, powerful drugs lauded for dramatically lowering low-density lipoproteins (LDL) the bad cholesterol - have been found to significantly decrease another risk factor for coronary-artery disease, researchers at UT Southwestern Medical Center at Dallas reported.

In the first head-to-head comparison of the effect of three commonly prescribed statins on remnant lipoprotein (RLP) cholesterol levels, the researchers reported in todays issue of Arteriosclerosis, Thrombosis and Vascular Biology that atorvastatin (Lipitor) and simvastatin (Zocor) significantly reduced RLP levels. Pravastatin (Pravachol), the third drug used in the study, had no significant effect on RLP levels.

Remnant lipoproteins, particles that circulate in the bloodstream much like LDL cholesterol, promote plaque formation in the arteries and subsequently are independent risk factors of coronary-artery disease.

Given that RLPs are atherogenic and promote plaque formation, it is not unreasonable to attribute part of the benefit of statins in reducing cardiovascular events to the reduction in RLP levels, said Dr. Ishwarlal Jialal, professor of pathology and internal medicine at UT Southwestern and senior author of the study. Its clinically proven that statins lower LDL and reduce cardiovascular events. Results from this study provide evidence of another mechanism by which statins are beneficial.

Twenty-two patients with combined hyperlipidemia (LDL levels greater than 130 milligrams per deciliter and triglyceride levels between 160 and 600 mg/dL) randomly received 40 mg of pravastatin, 20 mg of simvastatin and 10 mg of atorvastatin for six weeks per medication. A three-week washout period followed the administration of each drug.

The RLP levels were tested using a novel assay that utilizes a gel containing specific antibodies, said Dr. Sridevi Devaraj, assistant professor of pathology. The antibodies bind to HDL and LDL, as well a
'"/>

Contact: Amy Shields
Amy.Shields@UTSouthwestern.edu
214-648-3404
UT Southwestern Medical Center
12-Dec-2001


Page: 1 2

Related biology news :

1. Researchers develop white wine with cholesterol-lowering benefits, discover Israeli wines healthier than French wines
2. Soy isoflavones have a modest cholesterol-lowering effect in postmenopausal women
3. Genetic model for devastating form of paraplegia suggests new treatments
4. Fox Chase discovery may help physicians diagnose, treat devastating childhood disease
5. Vanderbilt doctors find citrus soda interacts with cyclosporine, maybe statins
6. Devastating parasitic weed may be felled by toxin borrowed from flies
7. Migraine mouse provides insight into neurobiology of devastating headaches
8. Rb proteins role in retina development is key to understanding devastating eye cancer
9. California pistachio industry threatened by potentially devastating disease
10. Endostatin also effective on head and neck cancers
11. Endostatin promising treatments for AIDS-related cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/6/2018)... ... November 06, 2018 , ... Genedata, a ... Stedim Cellca GmbH, a subsidiary of Sartorius Stedim Biotech (SSB) and a specialist ... the Genedata Bioprocess ® enterprise platform to be used at SSB laboratories ...
(Date:11/3/2018)... ... ... Karius , the leading infectious disease genomics company, is offering a ... patients. One grant of up to $50,000 will be awarded to a research institution ... addition to the funding, Karius will cover the cost of sequencing a limited number ...
(Date:11/3/2018)... Calif. (PRWEB) , ... November 01, 2018 , ... ... concerned with the morphology, physiology and pathology of the human dental pulp and ... the anatomy of the human teeth, but, over the last decade, non-destructive, high-resolution ...
Breaking Biology News(10 mins):
(Date:11/9/2018)... ... November 08, 2018 , ... uBiome, ... co-Founder, Chief Executive Officer and President of Andes Biotechnologies, to its Scientific Advisory ... Dr. Valenzuela brings to uBiome expertise on the genetic studies of hepatitis viruses. ...
(Date:11/6/2018)... ... November 06, 2018 , ... Crucial Data Solutions ... collection and management. TrialKit ™, an eClinical platform, has incorporated Apple’s biometric ... and easily sign in to the app via facial recognition or fingerprint recognition. ...
(Date:11/3/2018)... , ... November 01, 2018 , ... ... Champion Consortium Summit. Dr. Jean Mulinde, Senior Advisor, Division of Clinical Compliance Evaluation, ... monitor safety and ensure data reliability. , What should clinical research industry stakeholders ...
(Date:10/31/2018)... ... October 30, 2018 , ... The assessment of cell ... aspect of experimental biology. Reproducibility of cell-based assays is one of the key ... appropriate assay type, there are many more factors to be considered to decrease ...
Breaking Biology Technology:
Cached News: